Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 359.19 Thousand USD | -37.45% |
| 2021 | 574.25 Thousand USD | -71.62% |
| 2020 | 2.02 Million USD | 1175.01% |
| 2019 | 158.71 Thousand USD | 403.15% |
| 2018 | 31.54 Thousand USD | -99.16% |
| 2017 | 3.75 Million USD | 111.49% |
| 2016 | 1.77 Million USD | -66.51% |
| 2015 | 5.29 Million USD | 940.88% |
| 2014 | 509 Thousand USD | 13.66% |
| 2013 | 447.82 Thousand USD | -11.15% |
| 2012 | 504 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 2000.00 USD | -84.62% |
| 2004 | 13 Thousand USD | -89.52% |
| 2003 | 124 Thousand USD | 235.14% |
| 2002 | 37 Thousand USD | 311.11% |
| 2001 | 9000.00 USD | -79.55% |
| 2000 | 44 Thousand USD | -66.15% |
| 1999 | 130 Thousand USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 100 Thousand USD | -66.67% |
| 1996 | 300 Thousand USD | -80.0% |
| 1995 | 1.5 Million USD | -64.29% |
| 1994 | 4.2 Million USD | 14.44% |
| 1993 | 3.67 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 271.54 Thousand USD | -14.09% |
| 2023 Q1 | 316.07 Thousand USD | -12.0% |
| 2023 Q3 | 225.01 Thousand USD | -17.14% |
| 2022 Q2 | 456.38 Thousand USD | -16.54% |
| 2022 Q1 | 546.84 Thousand USD | -4.77% |
| 2022 Q4 | 359.19 Thousand USD | -10.41% |
| 2022 Q3 | 400.93 Thousand USD | -12.15% |
| 2022 FY | 359.19 Thousand USD | -37.45% |
| 2021 Q2 | 1.48 Million USD | 0.78% |
| 2021 Q4 | 574.25 Thousand USD | -10.33% |
| 2021 FY | 574.25 Thousand USD | -71.62% |
| 2021 Q1 | 1.47 Million USD | -26.95% |
| 2021 Q3 | 640.38 Thousand USD | -57.01% |
| 2020 Q2 | 1.63 Million USD | 1382.71% |
| 2020 Q1 | 109.98 Thousand USD | -30.7% |
| 2020 Q3 | 3.09 Million USD | 89.97% |
| 2020 Q4 | 2.02 Million USD | -34.68% |
| 2020 FY | 2.02 Million USD | 1175.01% |
| 2019 Q2 | 242.7 Thousand USD | -9.59% |
| 2019 Q1 | 268.43 Thousand USD | 751.02% |
| 2019 FY | 158.71 Thousand USD | 403.15% |
| 2019 Q4 | 158.71 Thousand USD | -26.39% |
| 2019 Q3 | 215.6 Thousand USD | -11.17% |
| 2018 Q4 | 31.54 Thousand USD | -21.02% |
| 2018 FY | 31.54 Thousand USD | -99.16% |
| 2018 Q2 | 8.29 Million USD | 118.56% |
| 2018 Q1 | 3.79 Million USD | 1.12% |
| 2018 Q3 | 39.94 Thousand USD | -99.52% |
| 2017 Q2 | 4.06 Million USD | 193.19% |
| 2017 Q1 | 1.38 Million USD | -21.81% |
| 2017 FY | 3.75 Million USD | 111.49% |
| 2017 Q4 | 3.75 Million USD | -24.58% |
| 2017 Q3 | 4.97 Million USD | 22.3% |
| 2016 Q3 | 1.39 Million USD | -57.68% |
| 2016 Q1 | 4.96 Million USD | -6.21% |
| 2016 Q2 | 3.3 Million USD | -33.5% |
| 2016 FY | 1.77 Million USD | -66.51% |
| 2016 Q4 | 1.77 Million USD | 26.86% |
| 2015 Q3 | 167 Thousand USD | -49.85% |
| 2015 FY | 5.29 Million USD | 940.88% |
| 2015 Q2 | 333 Thousand USD | 2.46% |
| 2015 Q1 | 325 Thousand USD | 2.52% |
| 2015 Q4 | 5.29 Million USD | 3072.5% |
| 2014 Q4 | 317 Thousand USD | 2.59% |
| 2014 FY | 509 Thousand USD | 13.66% |
| 2014 Q1 | 509 Thousand USD | 0.2% |
| 2014 Q3 | 309 Thousand USD | -39.53% |
| 2014 Q2 | 511 Thousand USD | 0.39% |
| 2013 Q4 | 508 Thousand USD | 0.2% |
| 2013 Q3 | 507 Thousand USD | 0.4% |
| 2013 Q2 | 505 Thousand USD | 0.2% |
| 2013 Q1 | 504 Thousand USD | 0.0% |
| 2013 FY | 447.82 Thousand USD | -11.15% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | 1.99 Million USD | 0.0% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | 504 Thousand USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q3 | 2000.00 USD | 0.0% |
| 2006 Q1 | 2000.00 USD | -60.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q2 | - USD | -100.0% |
| 2006 Q4 | - USD | -100.0% |
| 2005 Q2 | 13 Thousand USD | 0.0% |
| 2005 Q4 | 5000.00 USD | -28.57% |
| 2005 Q1 | 13 Thousand USD | -23.53% |
| 2005 FY | 2000.00 USD | -84.62% |
| 2005 Q3 | 7000.00 USD | -46.15% |
| 2004 Q4 | 17 Thousand USD | -85.22% |
| 2004 Q2 | 109 Thousand USD | -12.1% |
| 2004 FY | 13 Thousand USD | -89.52% |
| 2004 Q1 | 124 Thousand USD | 129.63% |
| 2004 Q3 | 115 Thousand USD | 5.5% |
| 2003 Q1 | 37 Thousand USD | -7.5% |
| 2003 Q3 | 32 Thousand USD | -11.11% |
| 2003 FY | 124 Thousand USD | 235.14% |
| 2003 Q4 | 54 Thousand USD | 68.75% |
| 2003 Q2 | 36 Thousand USD | -2.7% |
| 2002 Q4 | 40 Thousand USD | 400.0% |
| 2002 Q1 | 9000.00 USD | -10.0% |
| 2002 Q2 | 47 Thousand USD | 422.22% |
| 2002 FY | 37 Thousand USD | 311.11% |
| 2002 Q3 | 8000.00 USD | -82.98% |
| 2001 Q4 | 10 Thousand USD | 0.0% |
| 2001 Q1 | 44 Thousand USD | -32.31% |
| 2001 Q2 | 22 Thousand USD | -50.0% |
| 2001 FY | 9000.00 USD | -79.55% |
| 2001 Q3 | - USD | -100.0% |
| 2000 FY | 44 Thousand USD | -66.15% |
| 2000 Q3 | 87 Thousand USD | -20.18% |
| 2000 Q4 | 65 Thousand USD | -25.29% |
| 2000 Q2 | 109 Thousand USD | -16.15% |
| 2000 Q1 | 130 Thousand USD | -35.0% |
| 1999 FY | 130 Thousand USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | 200 Thousand USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q4 | - USD | -100.0% |
| 1998 FY | - USD | -100.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1997 FY | 100 Thousand USD | -66.67% |
| 1997 Q4 | 100 Thousand USD | -66.67% |
| 1997 Q1 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 300 Thousand USD | 0.0% |
| 1997 Q2 | 300 Thousand USD | 0.0% |
| 1996 Q3 | 600 Thousand USD | -50.0% |
| 1996 Q4 | - USD | -100.0% |
| 1996 FY | 300 Thousand USD | -80.0% |
| 1996 Q1 | 1.5 Million USD | -28.57% |
| 1996 Q2 | 1.2 Million USD | -20.0% |
| 1995 Q4 | 2.1 Million USD | -61.61% |
| 1995 FY | 1.5 Million USD | -64.29% |
| 1995 Q3 | 5.47 Million USD | -6.97% |
| 1995 Q1 | 4.2 Million USD | 0.0% |
| 1995 Q2 | 5.88 Million USD | 40.0% |
| 1994 FY | 4.2 Million USD | 14.44% |
| 1993 FY | 3.67 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -5886.55% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 72.317% |
| Biocept, Inc. | 10.37 Million USD | 96.538% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 99.3% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.413% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | 34.253% |
| iMD Companies, Inc. | 1.1 Million USD | 67.455% |
| IDenta Corp. | 428.17 Thousand USD | 16.111% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 91.534% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -29.206% |
| NovelStem International Corp. | 3.32 Million USD | 89.196% |
| Optigenex Inc. | 4.42 Million USD | 91.886% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 77.977% |
| Response Genetics, Inc | 4.91 Million USD | 92.696% |
| RushNet, Inc. | 4.25 Million USD | 91.553% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -44.225% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | 55.013% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | 37.681% |
| Todos Medical Ltd. | 33 Million USD | 98.912% |